ArticleBMC public health2006
Steep HIV prevalence declines among young people in selected Zambian communities: population-based observations (1995-2003).
Article in BMC public health, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Pooled it
- Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approaches.PLoS medicine · 2013Pooled it
- Uptake of home-based voluntary HIV testing in sub-Saharan Africa: a systematic review and meta-analysis.PLoS medicine · 2012Pooled it
- Sex Differences in HIV Prevalence Persist over Time: Evidence from 18 Countries in Sub-Saharan Africa.PloS one · 2016Trial
- Contrasting HIV prevalence trends among young women and men in Zambia in the past 12 years: data from demographic and health surveys 2002-2014.BMC infectious diseases · 2019Article
- Article
- Article
- Assessing and adjusting for differences between HIV prevalence estimates derived from national population-based surveys and antenatal care surveillance, with applications for Spectrum 2013.AIDS (London, England) · 2014Article
- Decline in sexual risk behaviours among young people in Zambia (2000-2009): do neighbourhood contextual effects play a role?PloS one · 2013Article
- Condom availability in high risk places and condom use: a study at district level in Kenya, Tanzania and Zambia.BMC public health · 2012Article
- Health status and socio-economic factors associated with health facility utilization in rural and urban areas in Zambia.BMC health services research · 2012Article
- The burden of knowing: balancing benefits and barriers in HIV testing decisions. a qualitative study from Zambia.BMC health services research · 2012Article
- Article
- Practicing provider-initiated HIV testing in high prevalence settings: consent concerns and missed preventive opportunities.BMC health services research · 2011Article
- Home-based voluntary HIV counselling and testing found highly acceptable and to reduce inequalities.BMC public health · 2010Article
- Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges.HIV therapy · 2009Article
- Effects of neighbourhood-level educational attainment on HIV prevalence among young women in Zambia.BMC public health · 2009Article
- Tuberculosis infection in Zambia: the association with relative wealth.The American journal of tropical medicine and hygiene · 2009Article
- Declining HIV prevalence among young pregnant women in Lusaka, Zambia.Bulletin of the World Health Organization · 2008Article
- Lost opportunities in HIV prevention: programmes miss places where exposures are highest.BMC public health · 2008Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUnderstanding the epidemiological HIV context is critical in building effective setting-specific preventive strategies. We examined HIV prevalence patterns in selected communities of men and women aged 15-59 years in Zambia.
methodsPopulation-based HIV surveys in 1995 (n = 3158), 1999 (n = 3731) and 2003 (n = 4751) were conducted in selected communities using probability proportional to size stratified random-cluster sampling. Multivariate logistic regression and trend analyses were stratified by residence, sex and age group. Absence, <30% in men and <15% in women in all rounds, was the most important cause of non-response. Saliva was used for HIV testing, and refusal was <10%.
resultsAmong rural groups aged 15-24 years, prevalence declined by 59.2% (15.7% to 6.4%, P < 0.001) in females and by 44.6% (5.6% to 3.1%, P < 0.001) in males. In age-group 15-49 years, declines were less than 25%. In the urban groups aged 15-24, prevalence declined by 47% (23.4% to 12.4%, P < 0.001) among females and 57.3% (7.5% to 3.2%, P = 0.001) among males but were 32% and 27% in men and women aged 15-49, respectively. Higher educated young people in 2003 had lower odds of infection than in 1995 in both urban [men: AOR 0.29(95% CI 0.14-0.60); women: AOR 0.38(95% CI 0.19-0.79)] and rural groups [men: AOR 0.16(95% CI 0.11-0.25), women: AOR 0.10(95% CI 0.01-7.34)]. Although higher mobility was associated with increased likelihood of infection in men overall, AOR, 1.71(95% CI 1.34-2.19), prevalence declined in mobile groups also (OR 0.52 95% CI 0.31-0.88). In parallel, urban young people with > or =11 school years were more likely to use condoms during the last casual sex (OR 2.96 95% CI 1.93-4.52) and report less number of casual sexual partners (AOR 0.33 95% CI 0.19-0.56) in the last twelve months than lower educated groups.
conclusionSteep HIV prevalence declines in young people, suggesting continuing declining incidence, were masked by modest overall declines. The concentration of declines in higher educated groups suggests a plausible association with behavioural change.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.